Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature

by Divyanshu Dubey, Yinan Zhang, Donna Graves, Allen D. DeSena, Elliot Frohman, Benjamin Greenberg
Published 2016-05-01

Current and emerging therapies in multiple sclerosis: a systematic review

by Wanda Castro-Borrero, Donna Graves, Teresa C. Frohman, Angela Bates Flores, Paula Hardeman, Diana Logan, Megan Orchard, Benjamin Greenberg, Elliot M. Frohman
Published 2012-07-01

Symptomatic therapy in multiple sclerosis

by Teresa C. Frohman, Wanda Castro, Anjali Shah, Ardith Courtney, Jeffrey Ortstadt, Scott L. Davis, Diana Logan, Thomas Abraham, Jaspreet Abraham, Gina Remington, Katherine Treadaway, Donna Graves, John Hart, Olaf Stuve, Gary Lemack, Benjamin Greenberg, Elliot M. Frohman
Published 2011-03-01

A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients

by Ann J. Ligocki, Jacqueline R. Rivas, William H. Rounds, Alyssa A. Guzman, Min Li, Melania Spadaro, Lauren Lahey, Ding Chen, Paul M. Henson, Donna Graves, Benjamin M. Greenberg, Elliot M. Frohman, E. Sally Ward, William Robinson, Edgar Meinl, Charles L. White, Ann M. Stowe, Nancy L. Monson
Published 2015-10-01